Ecto

About:

Ecto is a digital biology company developing technology to make protein production more efficient and sustainable

Website: https://www.ecto.com

Top Investors: National Science Foundation, Aqua Spark, Rabobank, Seventure Partners, The Yield Lab

Description:

Ecto develops technology at the intersection of data and biology to enable a more efficient and sustainable aquaculture industry. They collaborate with farmers to streamline production and health management by leveraging advanced molecular tools and digital technologies. To date, Ecto's solutions have enabled farmers to create 51,510,714 additional healthy servings of protein. Ecto has offices in Boston, Atlanta, and Stavanger Norway, and serves customers all over the world. The company was founded at Harvard Innovation Labs in 2013 by Dmitry Kozachenok and James Webb. The company has received competitive research grants from the US National Science Foundation, US Department of Agriculture, and Innovation Norway.

Total Funding Amount:

$20.6M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Atlanta, Georgia, United States

Founded Date:

2013-11-18

Contact Email:

contact(AT)ecto.com

Founders:

Dmitry Kozachenok, James Webb

Number of Employees:

11-50

Last Funding Date:

2023-10-20

IPO Status:

Private

Industries:

© 2025 bioDAO.ai